Cue Biopharma Inc (CUE)

1.025 0.00 (0.00%) USD  |  NASDAQ  |  Dec 20, 16:00
1.03 0.00 (0.00%) After-Hours: 20:00
More

Cue Biopharma EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to EBITDA Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to EBITDA Definition

View EV to EBITDA Definition
Start Trial

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

View EV to EBITDA Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

View EV to EBITDA Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp --
GlycoMimetics Inc --
FibroGen Inc --
Cidara Therapeutics Inc --

EV to EBITDA Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade